Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Magic Genomix logo — One Patient : One Treatment

Magic Genomix

One Patient : One Treatment

Founded 2023 France France 7 employees Unknown

General Information

Company Name Magic Genomix
Founded Year 2023
Location France France +2
Employees 7
Funding Stage Unknown
Social

Get notified when Magic Genomix moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Magic Genomix

Magic Genomix, founded in 2023 and headquartered in France, is a promising precision oncology deeptech startup. With the slogan "One Patient : One Treatment," the company is leveraging genomic instability biomarkers to revolutionize cancer treatment and mitigate risks in drug development.

Their proprietary platform includes tools such as Magic X and Magic Tween, which convert complex clinical and multimodal data into actionable insights. Magic X is particularly noteworthy for its ability to stratify chemotherapy response into actionable categories, demonstrating strong predictive capabilities for soft tissue sarcoma and expanding into ovarian, lung, and breast cancers.

Backed by a spinout investment from INSERM in January 2023, Magic Genomix presents a well-defined strategy for regulatory approval and commercialization. The company is positioned to improve cancer patient outcomes significantly, marking a remarkable step in personalized medicine.

Taxonomy: Precision Oncology, DeepTech Startup, Genomic Instability Biomarkers, Personalized Cancer Treatment, Drug Development, Clinical Data Analysis, Biopsy Data Analysis, Chemotherapy Response Prediction, Soft Tissue Sarcoma, Ovarian Cancer, Lung Cancer, Breast Cancer, Targeted Therapy, Immunotherapy, Regulatory Approval

Services & Products

Genomic data analysis
Biomarker identification and stratification
Drug response signature analysis
Patient stratification for clinical trials
Magic X software and service offerings

Target Customers

Pharmaceutical Industries Biotech Companies Healthcare Professionals Clinical Researchers

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Spinout •••••• 1 •••• •••• 01 Jan 2023

Magic Genomix Alternatives & Competitors

View All Alternatives
Magic Genomix vs
Novigenix SA
Novigenix SA Switzerland

Leader in Immuno-Transcriptomic Precision Medicine solutions

Series B
26 employees
AI, Analytics
Magic Genomix vs
ForceMetrics
ForceMetrics United States

Safety starts with understanding. We make responders safer and more effective.

Seed
39 employees
Analytics, Data Analytics
Magic Genomix vs
Codex Genetics
Codex Genetics Hong Kong S.a.r.

Unraveling your uniqueness

Seed
12 employees
Biotechnology
Also compare with: Magic Genomix vs GenomOncology GenomOncology View all alternatives

FAQ About Magic Genomix

One Patient : One Treatment
Magic Genomix was founded in 2023.
Magic Genomix is headquartered in France.
Magic Genomix has approximately 7 employees.
Magic Genomix has completed 1 funding round. The latest funding stage is Unknown.
Magic Genomix offers: Genomic data analysis, Biomarker identification and stratification, Drug response signature analysis, Patient stratification for clinical trials, Magic X software and service offerings.
Top alternatives and competitors to Magic Genomix include Novigenix SA, ForceMetrics, Codex Genetics, ACT Genomics, GenomOncology. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Magic Genomix and Novigenix SA are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Magic Genomix and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy